Greater Cannabis Company

Greater Cannabis Company is a fully listed biopharmaceutical company focused on developing new and effective cannabinoid therapies. The company conducts medical research and is currently undergoing clinical trials to develop innovative cannabis-based treatments for various diseases and their symptoms, with an initial focus on neuropsychiatric disorders. GCANRx's mission is to bring its products to the global market, benefiting patients seeking better solutions to meet their unmet medical needs.